Imaging agent to improve prostate cancer detection
Category: News
UCB’s BIMZELX reveals promising two-year data at EHSF 2025
New immunotherapy offers hope for recurrent cervical cancer
Treatment expands options for HER2-negative metastatic breast cancer
New methodology may boost innovation in protein engineering
CSL Behring’s study reveals significant long-term benefits
Partnership aims to leverage cutting-edge technology in clinical trials
Designation follows promising preclinical data and FDA clearance
Breast cancer therapy offers hope for patients at risk of recurrence